The ventrogluteal site, located on the side of the hip over the gluteus medius muscle, is the safest and most recommended location for intramuscular injections in the gluteal region. It sits far from major nerves and blood vessels, offers thick muscle tissue in most people, and is accessible in almost any patient position. Despite strong evidence in its favor, the technique intimidates many clinicians because the anatomical landmarks feel less familiar than the traditional upper-outer-buttock approach most people learned first.
Why the Ventrogluteal Site Is Preferred
For decades, the default gluteal injection site was the dorsogluteal, the upper-outer quadrant of the buttock. That site carries a well-documented risk of sciatic nerve injury, either from the needle itself or from the injected medication spreading into the nerve’s surrounding tissue. A cadaver study measuring the distance from each injection site to the sciatic nerve found that the ventrogluteal site averaged about 18 cm away, while the dorsogluteal site averaged only about 9 cm away in lean patients.1PubMed Central. Adverse effects of dorsogluteal intramuscular injection versus ventrogluteal intramuscular injection: A systematic review and meta‐analysis That difference is substantial when you consider that nerve injury from a gluteal injection can cause pain, numbness, or even foot drop that lasts months or becomes permanent.
The ventrogluteal site also sits farther from major blood vessels. One cadaver study measured the distance from the injection point to the superior gluteal artery and nerve at both sites. At the ventrogluteal site, the artery was roughly 14 mm away and the nerve about 12 mm away, compared with roughly 7 mm and 6 mm at the dorsogluteal site.2PubMed. The evaluation of dorsogluteal and ventrogluteal injection sites: a cadaver study In practical terms, you are about twice as far from the nearest structures you could accidentally hit.
There is one area where the ventrogluteal site does not clearly outperform the dorsogluteal site: the risk of accidentally depositing medication into subcutaneous fat instead of muscle. A meta-analysis pooling data from over 360 participants found that roughly a third of ventrogluteal injections ended up in subcutaneous tissue, a rate that was not statistically different from the dorsogluteal site.1PubMed Central. Adverse effects of dorsogluteal intramuscular injection versus ventrogluteal intramuscular injection: A systematic review and meta‐analysis This means choosing the right needle length for the individual patient matters just as much as choosing the right site.
How to Find the Ventrogluteal Site
The classic technique is called the V method. You place the heel of your hand on the patient’s greater trochanter, the bony bump at the top of the outer thigh. Point your index finger toward the anterior superior iliac spine, the bony point at the front of the hip you can feel through the skin. Spread your middle finger back along the iliac crest, the ridge of bone running along the top of the pelvis. The injection goes into the V-shaped triangle formed between those two fingers.3PubMed Central. Evaluating the effectiveness of gluteal intramuscular injection sites: a cadaveric study Use your opposite hand for landmarking: your left hand on the patient’s right hip, or your right hand on the patient’s left hip.
A newer approach called the G method (geometric method) uses fixed anatomical points rather than finger-spread to identify the site. Research comparing the two methods found the G method produced a thicker muscle target and a higher rate of successful intramuscular delivery: about 75% compared with 57% for the V method. The G method also carried less risk of hitting bone.4PubMed. Comparison of the G and V methods for ventrogluteal site identification: Muscle and subcutaneous fat thicknesses and considerations for successful intramuscular injection The G method works by drawing an imaginary line between two fixed bony landmarks and injecting at a calculated midpoint, which removes the subjectivity of how far apart you spread your fingers. Ultrasound confirmation studies have verified that muscle tissue is present under sites identified by both methods, though the G method tends to hit a meatier spot.5International Journal of Nursing Studies. The reliability of site determination methods in ventrogluteal area injection: A cross-sectional study
If you are new to this site and nervous about landmarking, there is a simple self-check. After placing your hand and identifying the triangle, press firmly with your fingertips. You should feel the firm bulk of muscle beneath the skin without any bony prominence directly under your target spot. If you feel the hard ridge of the iliac crest or the point of the greater trochanter right where you plan to insert the needle, you are too high or too low.
Performing the Injection Step by Step
Patient positioning is flexible, which is one of the practical advantages of this site. The patient can lie on their side with the top leg slightly bent forward, lie on their back, or even stand. Side-lying with the hip slightly flexed is most common because it relaxes the gluteus medius and makes the landmarks easy to palpate. If the patient is on their back, have them bend the knee on the injection side slightly to relax the hip.
The steps once you have gathered your supplies and confirmed the medication, dose, and patient identity:
- Clean the site: Use an alcohol swab and let it dry. Injecting through wet alcohol stings and can carry surface bacteria into the tissue.
- Stretch the skin: Use the Z-track technique. Pull the skin and subcutaneous tissue to one side with your non-dominant hand before inserting the needle. After injection and withdrawal, the displaced tissue slides back and seals the medication track, preventing leakage and reducing irritation.
- Insert at 90 degrees: Hold the syringe like a dart and insert the needle perpendicular to the skin in a quick, smooth motion. Hesitating partway through increases pain.
- Inject slowly: Push the plunger at a steady rate, roughly 1 mL per 10 seconds. Rapid injection forces medication into tissue faster than it can absorb, increasing pressure and pain.
- Withdraw and release: Pull the needle out at the same angle it went in, then release the Z-track skin. Apply gentle pressure with gauze but do not massage the site, as massaging can push medication back into subcutaneous tissue or cause unnecessary bruising.
Aspiration, the practice of pulling back on the plunger before injecting to check for blood, is no longer recommended for the ventrogluteal site by most current guidelines. The site lacks large blood vessels, so the risk of accidentally injecting into a vein is extremely low, and aspiration itself can increase tissue damage and pain.
Choosing the Right Needle Length
This is where many injections go wrong. A needle that is too short deposits medication into fat instead of muscle, which changes how the drug is absorbed, can cause sterile abscesses, and may reduce the effectiveness of vaccines. A needle that is too long risks hitting the periosteum, the sensitive tissue covering bone, which is deeply painful.
Body mass index is the strongest predictor of how much subcutaneous fat sits over the ventrogluteal muscle. One study of nearly 200 adults found a strong correlation between BMI and fat thickness at this site, with a correlation coefficient above 0.80 for both sexes. The study found that a standard 1.5-inch (3.75 cm) needle reaches muscle reliably in women with a BMI up to 30 and men with a BMI up to 35. Above those thresholds, the failure rate climbs dramatically: roughly 70% of injections in women with a BMI over 30 and about 60% in men with a BMI over 35 ended up in subcutaneous tissue when a 1.5-inch needle was used.6American Journal of Therapeutics. Body Mass Index: A Reliable Predictor of Subcutaneous Fat Thickness and Needle Length for Ventral Gluteal Intramuscular Injections Women carry more subcutaneous fat over the gluteal region than men at the same BMI, which is why the cutoff differs.
Practical needle-length guidance based on current research breaks down roughly as follows:7Medical Research Archives. Intramuscular Injection Guideline Revisions are Needed Based on Body Mass Index, Needle Length, Sex, and Skin to Muscle Depth
- Normal-weight women: A 1-inch to 1.5-inch needle (roughly 25 to 38 mm) typically reaches muscle.
- Overweight women: A 1.5-inch needle may still work, but some individuals need longer. The recommended range extends to about 62 mm.
- Normal-weight men: A 1-inch needle often suffices; the range is roughly 18 to 41 mm.
- Overweight or obese men: A 1.5-inch needle usually works, but the range can extend considerably in higher BMI categories.
A separate study put the general rule more simply: a 32-mm needle (roughly 1.25 inches) works at the ventrogluteal site for most men and for women at a normal weight. A 38-mm needle (1.5 inches) covers most women across weight categories.8PubMed. Influence of gender, BMI and body shape on theoretical injection outcome at the ventrogluteal and dorsogluteal sites For people in higher BMI ranges, both gluteal sites become unreliable, and clinicians may need to consider alternative sites or longer specialty needles.
Using the Ventrogluteal Site in Children
Many healthcare providers assume the ventrogluteal site is only for adults. Pediatric evidence tells a different story. A study measuring tissue thickness in children 36 months and younger found that the ventrogluteal site had suitable skin and muscle thickness for intramuscular injection across all age groups studied. The muscle at the ventrogluteal and anterolateral thigh sites was thicker than the deltoid, and the ventrogluteal site had acceptable dimensions even in the youngest infants.9PubMed. Investigation of suitability of ventrogluteal site for intramuscular injections in children aged 36 months and under
A randomized trial comparing the ventrogluteal site to the anterolateral thigh for hepatitis B vaccination in infants found the ventrogluteal site was both safe and effective, with comparable immune responses and no increase in adverse reactions.10International Journal of Nursing Studies. Safety and immunogenicity of hepatitis B vaccine administered into ventrogluteal vs. anterolateral thigh sites in infants: A randomised controlled trial This matters because the anterolateral thigh is the standard pediatric injection site for most vaccines, and having a safe alternative means clinicians can spread out injection locations when a child needs multiple shots at the same visit.
Considerations for Older Adults
Age-related muscle loss can raise questions about whether older adults have enough gluteal muscle for safe intramuscular injection. A study specifically examining older adults found that while both the dorsogluteal and ventrogluteal sites met the standard thresholds for intramuscular injection (subcutaneous tissue under 25 mm and total tissue over 35 mm), the ventrogluteal site had a clear advantage: more muscle thickness and less subcutaneous fat.11PubMed. Examining the Safety of Dorsogluteal and Ventrogluteal Sites for Intramuscular Injection in Older Adults For frail or very thin older adults, palpating the site carefully before injection and choosing an appropriately shorter needle helps avoid hitting bone.
Why So Many Clinicians Still Use the Dorsogluteal Site
Despite years of evidence favoring the ventrogluteal site, adoption has been slow. A Canadian study of hospital nurses found that seven out of ten used the dorsogluteal site for intramuscular injections, while only about 14% used the ventrogluteal site. Three-quarters of those nurses said they were aware of the risk of nerve damage at the dorsogluteal site, yet they continued using it anyway.12Journal of Advanced Nursing. Staff nurses’ sites of choice for administering intramuscular injections to adult patients in the acute care setting
The reasons are largely about training and comfort. A study examining barriers found that most nurses who avoided the ventrogluteal site cited a lack of knowledge about how to locate it and a fear of harming the patient.13PubMed Central. Creating a change in the use of ventrogluteal site for intramuscular injection The irony is hard to miss: clinicians avoid the safer site because they feel less confident with it, and continue using the riskier site because familiarity feels like safety. Nursing programs have gradually shifted to teaching the ventrogluteal site as the primary gluteal injection location, but clinical preceptors who trained in an earlier era sometimes steer students back to the dorsogluteal out of habit.
If you are a patient and a healthcare provider is about to give you a gluteal injection, it is perfectly reasonable to ask which site they plan to use. A provider comfortable with the ventrogluteal site will place their hand on the side of your hip, not the back of your buttock. If they are aiming for the upper-outer quadrant of the back of your buttock, they are using the dorsogluteal site.
Common Mistakes and How to Avoid Them
Even when clinicians choose the ventrogluteal site, certain errors can reduce effectiveness or cause complications:
- Landmarking on clothing: The bony landmarks need to be palpated through skin. Trying to landmark through jeans or thick fabric leads to guesswork. The patient needs to expose the hip area adequately.
- Using the wrong hand: If you use the same-side hand (right hand on the patient’s right hip), your fingers point the wrong direction and the V you form does not correspond to the correct anatomy. Always use the opposite hand for landmarking.
- Defaulting to a 1-inch needle for everyone: A 1-inch needle is fine for a lean man but may be too short for many women. Assess body composition before selecting needle length.
- Injecting too superiorly: If you slide your hand too far up the iliac crest, the injection site moves over thin tissue close to bone. The sweet spot is in the fleshy part of the triangle, not near its edges.
Self-Injection at the Ventrogluteal Site
People who self-administer medications like testosterone, certain biologics, or vitamin B12 sometimes choose the ventrogluteal site because it offers a larger muscle mass than the deltoid and is more comfortable than the vastus lateralis (outer thigh) for repeated injections. The challenge with self-injection here is that landmarking on yourself requires some contortion. Standing in front of a mirror helps. Place your opposite hand on your hip just as you would on a patient, identify the triangle, and mark the spot with a skin-safe marker before washing your hands and preparing the syringe.
The angle can feel awkward at first. Most people find it easiest to stand with their weight on the opposite leg, which relaxes the target hip. Inject from the side rather than trying to reach around from behind. After a few attempts, the motion becomes routine. If you regularly rotate injection sites, alternate between left and right ventrogluteal sites, or between the ventrogluteal and the vastus lateralis, to give tissue time to recover between injections.
One practical tip that experienced self-injectors often share: keep the syringe at room temperature for a few minutes before injecting, especially with oil-based medications. Cold, viscous solutions push harder against tissue and increase post-injection soreness. This applies regardless of which site you choose, but it is particularly noticeable in smaller muscles where the medication has less volume of tissue to disperse into.